12-125326673-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052907.3(TMEM132B):c.50G>A(p.Gly17Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000148 in 1,606,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052907.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM132B | NM_001366854.1 | c.68-22779G>A | intron_variant | ENST00000682704.1 | NP_001353783.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM132B | ENST00000682704.1 | c.68-22779G>A | intron_variant | NM_001366854.1 | ENSP00000507790.1 | |||||
TMEM132B | ENST00000299308.7 | c.50G>A | p.Gly17Glu | missense_variant, splice_region_variant | 1/9 | 5 | ENSP00000299308.3 | |||
TMEM132B | ENST00000535330.1 | n.123G>A | splice_region_variant, non_coding_transcript_exon_variant | 1/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152138Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000940 AC: 22AN: 234070Hom.: 0 AF XY: 0.000111 AC XY: 14AN XY: 126104
GnomAD4 exome AF: 0.000152 AC: 221AN: 1454184Hom.: 0 Cov.: 32 AF XY: 0.000138 AC XY: 100AN XY: 722224
GnomAD4 genome AF: 0.000105 AC: 16AN: 152138Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.50G>A (p.G17E) alteration is located in exon 1 (coding exon 1) of the TMEM132B gene. This alteration results from a G to A substitution at nucleotide position 50, causing the glycine (G) at amino acid position 17 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at